Topical Collection "Regulatory RNAs in Cardiovascular Development and Disease"

Editor

Dr. Yvan Devaux
E-Mail Website1 Website2
Guest Editor
Cardiovascular Research Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg

Topical Collection Information

Dear Colleagues,

Regulatory RNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), have attracted a great deal of attention from the cardiovascular community. They can be expressed in an organ-specific manner and participate in the regulation of important biological processes.

Several regulatory RNAs are dysregulated in many cardiovascular diseases, such as heart failure, hypertension, coronary artery disease, and myocardial infarction, suggesting that they might play an important role in regulating the expression of genes involved in such diseases.

In the last few years, different studies have demonstrated the importance of regulatory RNAs in cardiac development and cell differentiation.

The observation that regulatory RNAs can be found circulating in the blood supports their potential as disease markers. Recent studies present encouraging results for disease prognosis and therapy.

This Topical Collection is focused on the understanding of the role of regulatory RNAs (miRNAs, lncRNAs, circRNAs) in cardiovascular development and disease and their potential as biomarkers and therapeutic targets. We will consider original manuscripts, as well as reviews. Topics of interest include:

  • Regulatory RNAs in cardiovascular development
  • Regulatory RNAs in cardiovascular disease
  • Cardiovascular disease therapeutics involving regulatory RNAs
  • Regulatory RNAs as cardiovascular disease biomarkers
Dr. Yvan Devaux
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Non-Coding RNA is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heart
  • vascular system
  • cardiovascular disease
  • non-coding RNAs
  • regulatory RNAs
  • miRNAs
  • lncRNAs
  • circRNAs
  • biomarkers
  • functional genomics
  • transcriptomics
  • regulation of gene expression
  • collaboration
  • networking
  • precision medicine

Published Papers (5 papers)

2019

Jump to: 2018

Open AccessReview
Long Non-Coding RNA in Vascular Disease and Aging
Non-Coding RNA 2019, 5(1), 26; https://doi.org/10.3390/ncrna5010026 - 19 Mar 2019
Cited by 3
Abstract
Cardiovascular diseases are the most prominent cause of death in Western society, especially in the elderly. With the increasing life expectancy, the number of patients with cardiovascular diseases will rise in the near future, leading to an increased healthcare burden. There is a [...] Read more.
Cardiovascular diseases are the most prominent cause of death in Western society, especially in the elderly. With the increasing life expectancy, the number of patients with cardiovascular diseases will rise in the near future, leading to an increased healthcare burden. There is a need for new therapies to treat this growing number of patients. The discovery of long non-coding RNAs has led to a novel group of molecules that could be considered for their potential as therapeutic targets. This review presents an overview of long non-coding RNAs that are regulated in vascular disease and aging and which might therefore give insight into new pathways that could be targeted to diagnose, prevent, and/or treat vascular diseases. Full article
Show Figures

Figure 1

Open AccessArticle
Integrative System Biology Analyses Identify Seven MicroRNAs to Predict Heart Failure
Non-Coding RNA 2019, 5(1), 22; https://doi.org/10.3390/ncrna5010022 - 07 Mar 2019
Cited by 1
Abstract
Heart failure (HF) has several etiologies including myocardial infarction (MI) and left ventricular remodeling (LVR), but its progression remains difficult to predict in clinical practice. Systems biology analyses of LVR after MI provide molecular insights into this event such as modulation of microRNA [...] Read more.
Heart failure (HF) has several etiologies including myocardial infarction (MI) and left ventricular remodeling (LVR), but its progression remains difficult to predict in clinical practice. Systems biology analyses of LVR after MI provide molecular insights into this event such as modulation of microRNA (miRNA) that could be used as a signature of HF progression. To define a miRNA signature of LVR after MI, we use 2 systems biology approaches, integrating either proteomic data generated from LV of post-MI rat induced by left coronary artery ligation or multi-omics data (proteins and non-coding RNAs) generated from plasma of post-MI patients from the REVE-2 study. The first approach predicted that 13 miRNAs and 3 of these miRNAs would be validated to be associated with LVR in vivo: miR-21-5p, miR-23a-3p and miR-222-3p. The second approach predicted that 24 miRNAs among 1310 molecules and 6 of these miRNAs would be selected to be associated with LVR in silico: miR-17-5p, miR-21-5p, miR-26b-5p, miR-222-3p, miR-335-5p and miR-375. We identified a signature of 7 microRNAs associated with LVR after MI that support the interest of integrative systems biology analyses to define a miRNA signature of HF progression. Full article
Show Figures

Figure 1

Open AccessFeature PaperReview
Evolutionary Patterns of Non-Coding RNA in Cardiovascular Biology
Non-Coding RNA 2019, 5(1), 15; https://doi.org/10.3390/ncrna5010015 - 31 Jan 2019
Cited by 3
Abstract
Cardiovascular diseases (CVDs) affect the heart and the vascular system with a high prevalence and place a huge burden on society as well as the healthcare system. These complex diseases are often the result of multiple genetic and environmental risk factors and pose [...] Read more.
Cardiovascular diseases (CVDs) affect the heart and the vascular system with a high prevalence and place a huge burden on society as well as the healthcare system. These complex diseases are often the result of multiple genetic and environmental risk factors and pose a great challenge to understanding their etiology and consequences. With the advent of next generation sequencing, many non-coding RNA transcripts, especially long non-coding RNAs (lncRNAs), have been linked to the pathogenesis of CVD. Despite increasing evidence, the proper functional characterization of most of these molecules is still lacking. The exploration of conservation of sequences across related species has been used to functionally annotate protein coding genes. In contrast, the rapid evolutionary turnover and weak sequence conservation of lncRNAs make it difficult to characterize functional homologs for these sequences. Recent studies have tried to explore other dimensions of interspecies conservation to elucidate the functional role of these novel transcripts. In this review, we summarize various methodologies adopted to explore the evolutionary conservation of cardiovascular non-coding RNAs at sequence, secondary structure, syntenic, and expression level. Full article
Show Figures

Figure 1

2018

Jump to: 2019

Open AccessFeature PaperReview
Non-Coding RNAs to Aid in Neurological Prognosis after Cardiac Arrest
Non-Coding RNA 2018, 4(4), 42; https://doi.org/10.3390/ncrna4040042 - 18 Dec 2018
Abstract
Cardiovascular disease in general, and sudden cardiac death in particular, have an enormous socio-economic burden worldwide. Despite significant efforts to improve cardiopulmonary resuscitation, survival rates remain low. Moreover, patients who survive to hospital discharge have a high risk of developing severe physical or [...] Read more.
Cardiovascular disease in general, and sudden cardiac death in particular, have an enormous socio-economic burden worldwide. Despite significant efforts to improve cardiopulmonary resuscitation, survival rates remain low. Moreover, patients who survive to hospital discharge have a high risk of developing severe physical or neurological symptoms. Being able to predict outcomes after resuscitation from cardiac arrest would make it possible to tailor healthcare approaches, thereby maximising efforts for those who would mostly benefit from aggressive therapy. However, the identification of patients at risk of poor recovery after cardiac arrest is still a challenging task which could be facilitated by novel biomarkers. Recent investigations have recognised the potential of non-coding RNAs to aid in outcome prediction after cardiac arrest. In this review, we summarize recent discoveries and propose a handful of novel perspectives for the use of non-coding RNAs to predict outcome after cardiac arrest, discussing their use for precision medicine. Full article
Show Figures

Graphical abstract

Open AccessReview
Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection
Non-Coding RNA 2018, 4(3), 22; https://doi.org/10.3390/ncrna4030022 - 17 Sep 2018
Cited by 4
Abstract
Cardiovascular disease (CVD) is a significant cause of morbidity and mortality across the world. A large proportion of CVD deaths are secondary to coronary artery disease (CAD) and myocardial infarction (MI). Even though prevention is the best strategy to reduce risk factors associated [...] Read more.
Cardiovascular disease (CVD) is a significant cause of morbidity and mortality across the world. A large proportion of CVD deaths are secondary to coronary artery disease (CAD) and myocardial infarction (MI). Even though prevention is the best strategy to reduce risk factors associated with MI, the use of cardioprotective interventions aimed at improving patient outcomes is of great interest. Opioid conditioning has been shown to be effective in reducing myocardial ischemia-reperfusion injury (IRI) and cardiomyocyte death. However, the molecular mechanisms behind these effects are under investigation and could provide the basis for the development of novel therapeutic approaches in the treatment of CVD. Non-coding RNAs (ncRNAs), which are functional RNA molecules that do not translate into proteins, are critical modulators of cardiac gene expression during heart development and disease. Moreover, ncRNAs such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are known to be induced by opioid receptor activation and regulate opioid signaling pathways. Recent advances in experimental and computational tools have accelerated the discovery and functional characterization of ncRNAs. In this study, we review the current understanding of the role of ncRNAs in opioid signaling and opioid-induced cardioprotection. Full article
Show Figures

Graphical abstract

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

1) Shrey Gandhi, Frank Rühle and Monika Stoll. The evolution of non-coding RNA expression patterns in heart.

2) Diewertje Bink and Reinier Boon. long non-coding RNA in vascular disease and aging.

3) Emma L Robinson and Stephane Heymans. The missing ‘lnc’ between the genetics and cardiac disease.

4) Henri Charrier, Marie Cuvelliez, Emilie Dubois-Deruy, Paul Mulder, Vincent Richard, Christophe Bauters and Florence Pinet. Identification of seven microRNAs associated with heart failure using systems biology approaches.

5) Ashish Yeri, Ane Salvador-Garicano, Guoping Li, Elizabeth Hutchins, Eric Alsop, Kendall Jensen and Saumya Das. Reliable estimation of microRNA isoforms in small RNA sequencing.

Back to TopTop